Download PDFPDF

Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson’s disease
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    STN-DBS in genetic Parkinson's disease patients
    • Simon Israeli-Korn, MBBChir, MRCP
    • Other Contributors:
      • Sharon Hassin-Baer, MD; Oren Cohen, MD; Rivka Inzelberg, MD

    Dear Editor,

    We have read with interest the article by Soulas and colleagues entitled "Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease". (1)The authors reported a committed suicide rate of at least 1% and a 2% attempted suicide rate in a retrospective cohort of Parkinson's disease (PD) patients who underwent bilateral subthalamic deep brain stimulation (STN DBS). T...

    Show More
    Conflict of Interest:
    None declared.